C.K. McWhorter Honoring Excellence Of Rolex: McWhorter Family Trust Recognizes Rolex as a Paragon of Timepiece Craftsmanship
C.K. McWhorter Honoring Excellence Of Rolex: McWhorter Family Trust Recognizes Rolex as a Paragon of Timepiece Craftsmanship By Granting Illustrious Trust Warrant
March 16, 2024 13:16 ET | McWhorter Foundation
C.K. McWhorter Honoring Excellence Of Rolex: McWhorter Family Trust Recognizes Rolex as a Paragon of Timepiece Craftsmanship
Cingulate_Logo_400x400_twitter.jpg
Cingulate to Attend DCAT Week 2024 in New York City
March 06, 2024 06:45 ET | Cingulate Inc.
KANSAS CITY, Kan., March 06, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Cingulate_Logo_400x400_twitter.jpg
Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors
February 13, 2024 06:45 ET | Cingulate Inc.
KANSAS CITY, Kan., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Cingulate_Logo_400x400_twitter.jpg
Cingulate Announces Closing of $7.5 Million Public Offering
February 06, 2024 16:15 ET | Cingulate Inc.
KANSAS CITY, Kan., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) (“Cingulate,” the “Company,” “we,” “our” or “us”), a biopharmaceutical company utilizing its proprietary Precision...
Cingulate_Logo_400x400_twitter.jpg
Cingulate Announces Pricing of $7.5 Million Public Offering
February 02, 2024 09:15 ET | Cingulate Inc.
KANSAS CITY, Kan., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) (“Cingulate,” the “Company,” “we,” “our” or “us”), a biopharmaceutical company utilizing its proprietary Precision...
Superblock to Provide Monthly Blockchain Reports on Bloomberg Terminal
Superblock to Provide Monthly Blockchain Reports on Bloomberg Terminal
January 29, 2024 09:00 ET | Superblock
SEOUL, South Korea, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Superblock, the main contributor of the ‘Over Protocol’ mainnet, provides a blockchain insight report to Bloomberg Terminal. Superblock...
Cingulate_Logo_400x400_twitter.jpg
Werth Family Investment Associates Converts Remaining $3.3M of Debt and Accrued Interest into Cingulate Equity at Premium to Market
January 29, 2024 06:45 ET | Cingulate Inc.
KANSAS CITY, Kan., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) (Cingulate), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery...
LOGO ND NW.png
Nano Dimension Announces Preliminary All Cash Proposal to Acquire Stratasys for $16.50 per share
December 23, 2023 09:00 ET | Nano Dimension Ltd.
Waltham, Mass., Dec. 23, 2023 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension”, or “Nano” or the “Company”), a leading supplier of Additively Manufactured Electronics...
Cingulate_Logo_400x400_twitter.jpg
Cingulate Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103 (buspirone)
December 01, 2023 09:00 ET | Cingulate Inc.
KANSAS CITY, Kan., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
MEF-DarkBlue-Logo.png
MEF Launches Enterprise Leadership Council with Esteemed Corporate Leaders
October 03, 2023 08:10 ET | MEF
MEF formed a council of senior executives from all major enterprise vertical markets to bring important end user perspective and involvement to MEF.